Nick Ede

Nick Ede

Chief Tech/Sci/R&D Officer chez IMUGENE LIMITED

Fortune : 1 M $ au 31/03/2024

Health Technology
Energy Minerals
Consumer Services

Profil

Nicholas Ede is currently the Director at Eden Peptide Pty Ltd.
and the Chief Technology Officer at Imugene Ltd.
He previously served as the Chief Executive Officer at Mimotopes Pty Ltd.
from 2006 to 2010 and at Adistem Pty Ltd.
from 2010 to 2011.
He also held the position of Director at Mimotopes Pty Ltd.
and Chief Operating Officer at Equatorial Coal Ltd.
Additionally, he was the Chief Technology Officer at Rhinomed Ltd.
from 2012 to 2013 and the Vice President-Chemistry at Novartis Australia Pty Ltd.
Dr. Ede obtained a doctorate degree from Monash University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/08/2023 17 600 000 ( 0,24% ) 1 M $ 31/03/2024

Postes actifs de Nick Ede

SociétésPosteDébut
IMUGENE LIMITED Chief Tech/Sci/R&D Officer 11/02/2013
Eden Peptide Pty Ltd. Director/Board Member -
Tous les postes actifs de Nick Ede

Anciens postes connus de Nick Ede

SociétésPosteFin
RHINOMED Chief Tech/Sci/R&D Officer 24/01/2013
Adistem Pty Ltd. Chief Executive Officer 01/10/2011
Chief Operating Officer 26/08/2010
Chief Executive Officer 01/03/2010
Corporate Officer/Principal -
Voir l'expérience en détail de Nick Ede

Formation de Nick Ede

Monash University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Nick Ede

Relations

32

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
RHINOMED

Health Technology

IMUGENE LIMITED

Health Technology

Entreprise privées5

Energy Minerals

Health Technology

Health Technology

Adistem Pty Ltd.

Eden Peptide Pty Ltd.

Voir les connexions sociétés